Matthew Lang

General Counsel, Myovant Sciences Ltd.

Companies

Structure Therapeutics Inc.Chief operating officer Apr 23, 2026 to now¹
Metsera, Inc.General counsel Apr 30, 2025 to now²
Lyell Immunopharma, Inc.Chief Business Officer Jul 20, 2023 to Feb 26, 2025³
Myovant Sciences Ltd.General counsel Jul 18, 2017 to Mar 10, 2023⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Structure Therapeutics Inc. GPCR184,614 shares⁵$4.1M at $22.19Apr 15, 2026
Lyell Immunopharma, Inc. LYEL162,500 shares⁶$1.3M at $8.19Feb 10, 2025
Myovant Sciences Ltd.0 shares⁷Mar 10, 2023
Metsera, Inc.0 shares⁸Nov 13, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 15, 2026Granted 184,614 shares of Structure Therapeutics Inc.⁵
Nov 13, 2025Returned to company 12,500 shares of Metsera, Inc.⁸
Feb 10, 2025Granted 112,500 shares of Lyell Immunopharma, Inc.⁶
Feb 9, 2024Granted 50,000 shares of Lyell Immunopharma, Inc.⁹
Mar 10, 2023Returned to company 241,158 shares of Myovant Sciences Ltd.⁷
Mar 10, 2023Returned to company 113,145 shares of Myovant Sciences Ltd.⁷
Jan 18, 2023Sold 1,272 shares at $26.89 of Myovant Sciences Ltd.¹⁰
Jan 4, 2023Sold 2,779 shares at $26.90 of Myovant Sciences Ltd.¹¹
Oct 18, 2022Sold 1,933 shares at $25.20 of Myovant Sciences Ltd.¹²
Oct 4, 2022Sold 3,679 shares at $24.40 of Myovant Sciences Ltd.¹³
Aug 15, 2022Sold 31,214 shares at $18.23 of Myovant Sciences Ltd.¹⁴
Aug 12, 2022Granted 124,780 shares of Myovant Sciences Ltd.¹⁴
Jul 18, 2022Sold 1,935 shares at $12.87 of Myovant Sciences Ltd.¹⁵
Jul 6, 2022Sold 3,702 shares at $13.40 of Myovant Sciences Ltd.¹⁶
Apr 19, 2022Sold 8,002 shares at $10.45 of Myovant Sciences Ltd.¹⁷
Apr 15, 2022Granted 111,111 shares of Myovant Sciences Ltd.¹⁸
Apr 5, 2022Sold 2,436 shares at $13.78 of Myovant Sciences Ltd.¹⁹
Jan 4, 2022Sold 4,475 shares at $16.27 of Myovant Sciences Ltd.²⁰
Oct 5, 2021Sold 6,671 shares at $21.62 of Myovant Sciences Ltd.²¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARStructure Therapeutics Inc., Chief operating officer
2
SEC EDGARMetsera, Inc., General counsel
3
SEC EDGARLyell Immunopharma, Inc., Chief Business Officer
4
SEC EDGARMyovant Sciences Ltd., General counsel
5
SEC EDGARStructure Therapeutics Inc. shares after the filing of Apr 15, 2026
6
SEC EDGARLyell Immunopharma, Inc. shares after the filing of Feb 10, 2025
7
SEC EDGARMyovant Sciences Ltd. shares after the filing of Mar 10, 2023
8
SEC EDGARMetsera, Inc. shares after the filing of Nov 13, 2025
9
SEC EDGARForm 4 filed Feb 13, 2024
10
SEC EDGARForm 4 filed Jan 20, 2023
11
SEC EDGARForm 4 filed Jan 5, 2023
12
SEC EDGARForm 4 filed Oct 20, 2022
13
SEC EDGARForm 4 filed Oct 6, 2022
14
SEC EDGARForm 4 filed Aug 16, 2022
15
SEC EDGARForm 4 filed Jul 20, 2022
16
SEC EDGARForm 4 filed Jul 8, 2022
17
SEC EDGARForm 4 filed Apr 21, 2022
18
SEC EDGARForm 4 filed Apr 19, 2022
19
SEC EDGARForm 4 filed Apr 7, 2022
20
SEC EDGARForm 4 filed Jan 6, 2022
21
SEC EDGARForm 4 filed Oct 7, 2021